AzTrials
AzTrials

HealthyNCT03286673

Comparison of Three Calcium Supplements

A study testing calcium phosphate, Tricalcium Phosphate and Calcium carbonate in people with Healthy, run by University of Jena.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study was conducted to investigate the metabolic effects of three different calcium compounds in healthy adults. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
calcium phosphate, Tricalcium Phosphate and Calcium carbonate
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
31 participants
Where
No sites listed yet
Study dates
Oct 2006to Mar 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • age 18 - 40 years

Who cannot join

  • diseases of the gastrointestinal tract
  • pregnancy
  • the intake of any medication (e. g. for thyroid gland)
  • intake of dietary supplements

About this study

Official title: Comparison of Three Calcium Supplements With Regard to Their Metabolic Effects in Healthy Adults

The study was conducted to investigate the metabolic effects of three different calcium compounds in healthy adults.

Conditions
Healthy
Being tested
calcium phosphate, Tricalcium Phosphate, Calcium carbonate, Placebo
Keywords
calcium carbonate, calcium phosphate, metabolic effects, human study, calcium and phosphorus metabolism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • calcium phosphateDietary supplement

  • Tricalcium PhosphateDietary supplement

  • Calcium carbonateDietary supplement

  • PlaceboDietary supplement

Study groups in NCT03286673
Study groupRoleWhat they receive
calcium phosphateExperimentalPentacalcium hydroxy-triphosphate (Ca5(PO4)3OH) was incorporated in wholemeal and crispy wafer bread in order to achieve a additional calcium intake of 1000 mg/d.
Receives: Dietary Supplement: calcium phosphate
Tricalcium PhosphateExperimentalβ-tricalcium phosphate (Ca3(PO4)2) as incorporated in wholemeal and crispy wafer bread in order to achieve a additional calcium intake of 1000 mg/d.
Receives: Dietary Supplement: Tricalcium Phosphate
Calcium carbonateExperimentalCalcium carbonate (CaCO3) was incorporated in wholemeal and crispy wafer bread in order to achieve a additional calcium intake of 1000 mg/d.
Receives: Dietary Supplement: Calcium carbonate
PlaceboActive comparatorWholemeal and crispy wafer bread without additional calcium additive.
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum mineral concentration

    Calcium and Phosphate (and others) concentration in serum.

    Measured: after 4 weeks of each intervention

  2. Stool mineral concentration

    Calcium and Phosphate concentration (and others) in stool from a three day stool collection

    Measured: after 4 weeks of each intervention

  3. Urine mineral concentration

    Calcium and Phosphate concentration (and others) in urine from a three day urine collection

    Measured: after 4 weeks of each intervention

  4. Lipids in blood

    Lipids and lipoprotein concentration in serum.

    Measured: after 4 weeks of each intervention

  5. Sterols

    Neutrals sterols and bile acids in stool from a three day stool collection

    Measured: after 4 weeks of each intervention

  6. Dietary intake

    Evaluation of the dietary intake using a three day weighed dietary record.

    Measured: after 4 weeks of each intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2017
  2. Study startOct 2006
  3. Primary completionMar 2007
  4. Study completionMar 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03286673
Sponsor's protocol ID
H28-06
Status last verified
Sep 2017
First submitted
11 Sep 2017
Last updated
18 Sep 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing calcium phosphate, Tricalcium Phosphate and Calcium carbonate in people with Healthy, run by University of Jena.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum mineral concentration (time frame: after 4 weeks of each intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in